Ricardo Blanco

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman et al. · The Lancet · 2013 · 714 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Dafna D. Gladman, William F. C. Rigby, Valderílio Feijó Azevedo et al. · New England Journal of Medicine · 2017 · 494 citations · Full text

Henoch‐Schönlein purpura in adulthood and childhood. Two different expressions of the same syndrome

Ricardo Blanco, Víctor M. Martínez‐Taboada, Vicente Rodríguez‐Valverde et al. · Arthritis & Rheumatism · 1997 · 417 citations · Full text

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu

Joel M. Kremer, Ricardo Blanco, Marek Brzosko et al. · Arthritis & Rheumatism · 2010 · 410 citations

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment

Miguel Á. González‐Gay, Ricardo Blanco, Vicente Rodríguez‐Valverde et al. · Arthritis & Rheumatism · 1998 · 403 citations